Juan Manuel O’Connor, MD, MSc, Instituto Alexander Fleming, Buenos Aires, Argentina, comments on current unmet needs in anal squamous cell carcinoma, including the need for new therapeutic strategies such as immunotherapy. Dr O’Connor additionally highlights the importance of novel biomarkers, which will improve patient outcomes. This interview took place at the ESMO World Congress on Gastrointestinal Cancer (WCGIC) 2023 in Barcelona, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.